CSE PREV
LAST 0.025
CHANGE 0.000
OTC PRVCF
FSE 18H
CSE: PREV
LAST: 0.025
CHANGE: 0.000
OTC: PRVCF
FSE: 18H

PreveCeutical (Australia) Pty Ltd.

PreveCeutical (Australia) Pty Ltd.

PreveCeutical has established a wholly owned subsidiary in Brisbane, Queensland, Australia to bolster their research and development interests.

 

Stephen Van Deventer

Chairman and Director

Mr. Van Deventer is an experienced business person and corporate director. Specialising in international corporate relations and business development over the last thirty years, Mr. Van Deventer has focused on launching small to medium-sized companies into the public markets in Canada, the United States and Europe. He has also owned and operated private businesses.

James Henderson

Director and Public Officer

Mr. Henderson has been a managing director of HLB Mann Judd Brisbane since 2010 and was recently appointed the chair of HLB Asia Pacific. He has received his MBA in Accounting Legal Studies from the Queensland University of Technology and is a Fellow with Chartered Accountants Australia & New Zealand and the Taxation Institute of Australia. Mr. Henderson has experience across a broad range of industries over the last 25 years, including property and construction, and enjoys the challenge of enhancing business performance to improve profitability.

Sign up for the latest news and updates